secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioCorRx Inc. (BICX)
CIK:        0001443863
Form:       8-K
Filed at:   2022-04-28T23:59:59+00:00
Accession:  0001477932-22-002702
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioCorRx adopts 2022 Omnibus Plan authorizing 695,000 shares for equity incentives
--------------------------------------------------------------------------------

- Board approved 2022 Omnibus Securities and Incentive Plan on April 22, 2022; replaces 2018 plan.
- Plan reserves 695,000 shares of common stock for future equity awards.
- Non-employee director annual compensation cap set at $300,000 (equity + cash).
- Outstanding 2018 plan awards continue; forfeited shares become available under 2022 plan.
- Plan permits options, restricted stock, units, performance units, SARs and distribution equivalent rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1443863/000147793222002702/0001477932-22-002702-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1443863/000147793222002702/bicx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-22-002702

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer